Innovative Partnership for Worker Safety
In a significant move towards enhancing healthcare safety, BD (Becton, Dickinson and Company) and ChemoGLO™ have announced a strategic collaboration aimed at expanding hazardous drug contamination testing in healthcare facilities. With the combined technological prowess of BD’s HD Check System and ChemoGLO™’s advanced analysis capabilities, healthcare workers can expect improved safety measures against hazardous drug exposure.
Streamlined Testing Process for Facilities
The partnership brings together the rapid results of the BD® HD Check System, which provides qualitative testing within just 10 minutes, along with ChemoGLO™’s quantitative LC-MS/MS analysis delivered within three to five days. This dual approach not only enables fast identification of contamination but also provides a comprehensive analysis to help pinpoint areas for improvement.
Addressing a Critical Need in Healthcare
The growing recognition of contamination risks associated with hazardous drugs has raised concerns within the medical community. According to Eric Borin, worldwide president of BD Medication Delivery Solutions, this collaboration addresses those concerns by ensuring healthcare facilities have the tools to monitor and manage contamination effectively. The integration of qualitative and quantitative testing methods aligns with recommendations from the 2020 consensus conference on hazardous drug surface contamination.
Commitment to Protect Healthcare Workers
Cara Zamboni, CEO at ChemoGLO™, emphasized the core mission of the collaboration, which is to protect health care workers and patients from hazardous drug exposure. This partnership represents a leap forward in healthcare safety, allowing facilities to act swiftly and confidently in response to contamination risks.
Looking Ahead: Future Implications
As healthcare facilities increasingly adopt these advanced testing methods, we can anticipate a marked improvement in the standards of safety for healthcare workers across regions, including Sussex County NJ and Northern NJ. The combined efforts of BD and ChemoGLO™ signify a proactive approach to tackling hazardous drug exposure, which remains a pressing issue in healthcare environments.
Write A Comment